Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The granulocyte-macrophage colony-stimulating factor (GM-CSF)-driven monocyte differentiation pathway describes the signaling cascade initiated by GM-CSF binding to its receptor on monocytes, leading to their differentiation into macrophages and dendritic cells. This pathway involves activation of JAK/STAT, MAPK, and PI3K signaling, ultimately influencing gene expression and cellular function. It plays a crucial role in immune responses and inflammation.
Varies depending on the specific drug target within the pathway. Examples include blocking GM-CSF binding to its receptor, inhibiting downstream signaling kinases, or modulating transcription factor activity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granulocyte-Macrophage Colony-Stimulating Factor-Driven Monocyte Differentiation Pathway.